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The recent theory of kindling may help to link neurophysiologic, neu rotransmitt er
and neuroanatomic mechanisms important in understanding th e neurology of behav-
ior . Lim bic kindling is of interest in developing model s of epilepsy, psychosis, learning
and memory (l -5). Kindling might explain the late development of psychopathology.
This paper will first define kindling and demonstrate how kindling offers a model
within which to view more prolonged behavioral deviations as neurophysiologica l
proces ses. The use of carbamazepine and its association to kindling, tempora l lobe
dysfunction and psychopathology will be discussed .
As originally defined by Goddard and Morrel (2), th e ter m kindli ng referred to
the observation that brief electrical st imulation of limbic and cortical a reas in rats by
currents that were originally inadequate to evoke after-discha rges or behaviora l
effects, eventually prod uces an after-discharge. When carried on long enough, kindling
stimulation lead s to spontaneous seizures. As suggested by the name, the term kindling
is an ana logy to the starting of a fire whereby application of low heat (or subthreshold
stimulation) ca uses wood (or bra in tissue) to burst into flames (or convul se). Kind ling
represents neurona l processes that ma y mediate the formation of lasting behaviora l
change. The process of kindling is not all or none (3). It involves a progressive, lasting
lowering of neuronal threshold to evoke an afterdischa rge. Both elec trical and
chemical stimuli can produce kindling (7) . Chronic administra tion of CNS stimulants
such as cocaine and ampheta mines may caus e increases in limb ic system discharges
and vulnerabil ity to pathologic behavior and seizures (8, 9) .
The concept of kindling has been applied to chronic psychological stress that
results in progressive vulnerability to pathologic behavior. It is known that environ-
ment al events can induce synchro nized electrical activity within the limbi c system.
There is evide nce of lasti ng cha nge in behavior following repeated limbic stimulation
with an d without changes in epi leptogenicity. Animal studies have shown full -blown
behaviora l convulsions after epileptic activation of the limbic system with out electro-
encephalographic evidence of seizures. It is not completely clear what role inter ictal
phenomena have on behavioral responses (lO). Kindling may explain why certain
temporal lobe epilepsy (TLE) patients develop behavioral changes and psychosis.
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Temporal Lobe Epilepsy (TLE)
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I would like to focus on temporal lobe epilepsy (TLE), a condition associate d with
personality disturbances (II, 12). Eighty-five percent of all persons with epilepsy have
temporal lobe-limbic system epileps y, in which the temporal lobe recruit s the rest of
the brain into a major motor seizure (13) . Some of the psychic experiences which may
occur during temporal lobe dysfunction that can mimic psychiat ric disorders ar e the
following (13 ,14):
Hallucinations (auditory, visual, olfactory, Excessive wat er drinking
tactile, gustatory or vertiginous) Dreamy sta te
Depersonalization Forced thinking
Deja vu Compulsive thinking
Jamais vu Confusion
Dere alization Amusia
Fear Aph asia
Paranoia Agnosi a
Elation Memory defects
Depression Hypergraphia
Anxiety Hyperreligiosity
Sexual disturbances Head ache
Cephalgic auras (micropsia, macropsia) Alimentar y symptoms
Crying and laughing episodes Running episodes
Thus it is not enough to ask a patient suspected of having TLE whether he has seizures,
convulsions or attacks of unconsciousness, and to leave it a t that. History-taking in
these cases demands a meticulous search for the more subtle types of tem poral lobe
attacks .
There are technical problems in identifying patients with temporal lobe-limbic
system dysfunction manifesting clinically as psychiatric disorders, i.e., explosive,
aggressive, borderline and antisocial person ality structures (13, 14, 15). These
individuals exhibit a wide variety of episodic behavioral disturbances including
free-floating anxiety, affective disorders, impulsive destructive rages, a typical psycho-
sis and mini-psychotic episodes (14, 15, 16, 17). Some of these patients demonstr ate
abnormal EEG activity, with clinical improvement after anticonvulsant medication
(18) . The problem is that temporal lobe-limbic system abnorma lities, whet her
associated with an ictal or interictal state, are seldom detected by cortica l, much less
scalp, recordings; thu s the clinical EEG is not a sensitiv e measur e of possible
neurophysiological correlates with behavior (19). In the future , computer ized analysis
of EEG and evoked potential data and Positron Emission Tomography (P ET ) could be
helpful (20, 21). In the meantime, physiological and drug-activated EEG's (sleep,
hyperventilation, sedatives and stimulants) with low temporal lobe leads or nasopha-
rynge al leads are presumed to be the most useful clinical measures of central nervous
system instability (22, 23) .
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The concept of psychosis and epilepsy has been written about for the last 200
years. In 1860 Morel reported the alterna tion of psychotic episodes with convulsions.
Lateralization was introduced into the work by Flor-Henry who reported left-sided
TLE being more frequently associated with schizophrenic-like symptoms and right-
sided lesions being associated with affective disorders (10).
Monroe has data that directly support the concept of limbic ictus as an etiological
mechanism in a group of patients with the diagnosis of atypical psychosis. Psychoses
were correlated with electrographic data recorded from chronically implanted subcor-
tical electrodes (14, 16, 17, 22, 23, 24, 25, 26) . Monroe describes a young female
patient diagnosed as having chronic paranoid schizophrenia who would become
psychotic with intense rage reactions. At this time dramatic electrograph ic abnormali-
ties from subcortical electrodes were noted although these a bnormalities were not
present in the corresponding scalp leads. During the intervals between attacks when
her chronic paranoid symptoms were the only deviant behavior noted , interictal types
of recordings were noted from subcortical electrodes (17). Ictal fear has been found by
neurosurgeons, who have implanted electrodes in the brain, to ari se from a medial
temporal focus in the region of the amygdala and hippocampus, i.e., limb ic system
lesions as opposed to lateral cortical lesions (3, 12). A recent study by Her man n
showed that a subgroup of TLE patients did have abnormal MMPI test dat a. This
subgroup was composed of TLE patients whose seizures began with fear (25) . These
patients showed elevated scores of MMPI Psychasthenia and Par anoia sca les.
The following question arises; is the psychosis seen in epilepsy relat ed to the
psychosis seen in non-epileptic patients? Perez and Trimble performed a recent st udy
on 24 patients with psychosis and epilepsy and II controls that just had psychosis
diagnosed clinically by two different psychiatrists (27 , 28) . The technique used the
examination of Wing (27). This examination collects symptoms by a standa rd
interview. This information is put into a computer using a special program which then
yeilds a computerized diagnosis of the psychosis to objectify the diagno sis. Twelve of
the epileptic psychotics were diagnosed as having a form of schizophrenia. Th e other
half had various other diagnoses. Eleven of the twelve had the nuclear schizophrenia
which was based on Schneiderian first rank symptoms. The group was divided up into
those that had generalized epilepsy and those that had TLE. Th is diagno sis was done
clinically and by an EEG . The results showed that only those patients with the nuclear
schizophrenia described by Schneider had TLE. Nuclear schizophrenia did not occur
in generalized epilepsy .
This is the most objective evidence obtained so far linking nuclear schizophrenia
and TLE. The study also looked at the profile between left and right TLE. Th e nuclear
syndrome appeared significantly more in left TLE. The laterality was establ ished by
an independent electroencephalographer, the diagnosis of nuclear schizophrenia by a
computer. This is a direct confirmation of the observations made in the sixties by
Flor-Henry of a direct link between left-sided TLE and nuclear schizophren ia (10,
26).
Studies supporting Flor-Henry's observation of right sided temporal lobe epilepsy
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in the nondominant hemisphere yielding affective psychosis can be found in the
literature (10, 26) . It is also important to note that in the majority of TLE pat ients the
epilepsy precedes the psychosis by several years.
Carbamazepine
Carbamazepine (CBZ) (Tegretol) was developed by l.R. Geigy in Basel,
Switzerland, in the 1950's (29) . Its anticonvulsant properties were described by
Theobold and Krinz in 1963, based on animal studies. The compound was introduced
in Europe as an antiepileptic in the early 1960's. Not until 1974 was CBZ approved for
use in epilepsy in the U.S. CBZ is chemically related to the tricyclic antidepressa nts,
such as imipramine.
The drug of choice for temporal lobe epilepsy is CBZ (13). Most pati ent s with
uncontrolled temporal lobe epilepsy have severe personality problems. There is a
dramatic change in behavior with control of the epilepsy, not seen with the use of
phenytoin and phenobarbital. Evidence has been accumulated which inicat es tha t
CBZ has beneficial psychotropic effects. Initially these effects were noted in psychiat-
ric syndromes associated with seizure disorders (30, 31).
CBZ has shown clinical usefulness in the following disorders:
I. Temporal lobe epilepsy (TLE, Partial complex seizures) (1 ,32)
2. Grand mal seizures (32)
3. Alcohol withdrawal seizures (33)
4. Mixed seizure patterns (32)
5. Kindling phenomenon in amygdala (34, 35, 36, 37)
6. Trigeminal neuralgia (38,39,40)
7. Tabes dorsalis (40,41)
8. Paraesthesias associated with multiple sclerosis
9. Paraesthesias associated with phantom limb (42)
10. Postherpetic neuralgia (43)
I I. G lossopharygeal neuralgia (44)
12. Digitalis-induced ventricular arrhythmias (45)
13. Motor and verbal tics in Gilles de la Tourette's syndrome (46 , 47)
14. Myokymia (48, 49)
15. Myoclonic tinnitus (50, 51, 52, 53)
16. Manic depressive illness (1,3, 14, 54-66)
17. Affective dysregulation of TLE (31)
18. Borderline personality disorder (I, 14, 15)
19. Atypical psychosis (14)
20. Episodic dyscontrol syndrome (3, 14, 17)
21. Limbic ictus with atypical psychosis (12, 14,66)
22. Schizophrenia (12, 60, 64)
23. Diabetes insipidus (67, 68, 69)
A mechanism which would explain the spectrum of usefulness of CBZ from
Use of Carbamazepine (Tegretol) in Psychiatry 19
paroxysmal or shooting pain to affective dysregulation is still uncl ear. Theories as to
the antidepressant and antimanic effects of CBZ have been related to the noradrener-
gic system and its ability to stabilize limbic system dysfunction. The possibility of a
previously undescribed antipsychotic effect or anticonvulsant (antikindling) effect has
to be considered. CBZ effects on GABA, opiates, vasopressin, somatosta tin a re but a
few areas of interest (I, 3, 62, 67, 68, 69, 70).
Although a number of theories suggest various mech anism of ac tion of C BZ, none
fully elucidates the molecular mechanism of action and the observed clinical efficacy
of this extremely important and interesting drug.
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